This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Molecular Genetics: André Bergman, Ph.D


André Bergman, Ph.DGroup Leader

About André Bergman

Research interest

Andre Bergman divides his time between treating cancer patients at the Antoni van Leeuwenhoek hospital, and working in the laboratory at the adjacent NKI, where he researches the mechanisms underlying prostate cancer development. Prostate cancer is the most prevalent malignant disease in men. It develops through distinct stages, and there is emerging evidence that the tumor microenvironment plays an important role in driving progression through the different stages. The Bergman group investigates the contribution of the microenvironment in prostate cancer development using both cancer models in the laboratory, as well as human prostate cancer. Their goal is to identify new mechanisms and targets that could be used to develop more effective therapeutic approaches.


Cioni, Bianca.jpg

Bianca Cioni

Ph.D Student


I studied Medical Biotechnology at University of Florence in Italy. Following a Master in Molecular Biotechnology at the University of Birmingham in UK, I started working at the NKI as a PhD student from October 2013. My project is funded by the Marie Curie European research grant for the Initial Training Network on Tumor Infiltrating Myeloid Compartment Cells (TIMCC) and is supervised by André Bergman and Jan Paul de Boer. In this project we aim to analyze the myeloid cells infiltration in the tumor microenvironment of human tissues from Prostate and Head and Neck cancer. We will mainly focus on macrophage differentiation in M1 or M2 subtype. Understanding the mechanism of  myeloid cell regulation in the microenvironment and its relation with tumor progression might be critical for the development of new treatment modalities.

Close this window
Nevedomskaya, Ekaterina.JPG

Ekaterina Nevedomskaya

Postdoctoral fellow


I completed my PhD in metabolomics under supervision of Prof. Dr. André Deelder and Dr. Oleg Mayboroda at the Leiden University Medical Center. Afterwards I stayed as a post-doc in the same group, spending time as a visiting researcher in the group of Dr. Hector Keun (Imperial College London) working on multi-omics data integration for understanding metabolism control in cancer.  Pursuing my interest in cancer biology I joined the labs of Wilbert Zwart, Lodewyk Wessels and Andre Bergman as a bioinformatics postdoc. My main project is analysis of androgen receptor genomics data for elucidation of treatment resistance in prostate cancer.



Close this window
Stelloo, Suzan.jpg

Suzan Stelloo, MSc

Ph.D. Student


I received my Bachelor degree in molecular biology from the hogeschool Utrecht, and then I graduated from the Utrecht University. During the master program Cancer Genomics & Developmental biology I performed an internship at the UMC Utrecht in the group of dr. Derksen and a second in the lab of Prof. Melino at the University Tor Vergata, Rome. In February 2013, I started as a PhD student in the lab of Wilbert Zwart & André Bergman. My work focuses on integrative androgen receptor genomics as a readout for recurrence risk and treatment resistance of prostate cancer.



Close this window

Research updates View All Updates

  • We are currently investigating the role of the adaptive immune system in initiation and development of prostate cancer in models of cancer and in human prostate cancer material.

Key publications View All Publications

  • Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the Netherlands

    Clin Genitourin Cancer. 2013

    Wissing MD, van Oort IM, Gerritsen WR, van den Eertwegh AJ, Coenen JL, Bergman AM, Gelderblom H.

    Link to Pubmed
  • Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.

    Urol Int. 2010; 84: 212-20

    van der Poel HG, Zevenhoven J, Bergman AM.

    Link to Pubmed

Recent publications View All Publications

  • Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer.

    Clin Genitourin Cancer. 2015 Feb;13:44-9

    Djajadiningrat RS, Bergman AM, van Werkhoven E, Vegt E, Horenblas S.

    Link to Pubmed
  • Nieuwe therapeutische mogelijkheden voor de behandeling van gemetastaseerd prostaatcarcinoom

    Ned. Tijdschr. Oncologie.2015, 12: 225-231

    AM Bergman

    Link to article


  • Office manager

    Marij Degen

  • E-mail


  • Telephone Number

    +31 (0)20 512 9134



'Research for the benefit of cancer patients'

Support us
Share this page